Signant & Ametris: Unified eCOA & Sensor Evidence for Clinical Trials

Every clinical trial is a story.
Today, the story is more complex.

Now multiple lines of evidence are required to demonstrate a treatment’s benefit. One dataset shows what patients say. Another reveals how they function in the real-world. Each perspective matters and only together do they show the full impact of treatment.

Signant Health is building the industry’s first end-to-end platform designed to deliver unified evidence from both modalities. eCOA and sensor-based wearables.

Unifying evidence across modalities to complete the patient picture in clinical trials–this is the breakthrough modern research has been waiting for.

5 REASONS TO CHOOSE SIGNANT HEALTH

01 Every Perspective Matters

One perspective is never enough to complete the patient picture. Patient-reported outcomes capture lived experience. Wearables capture real-world function. Now both come together through one trusted, reliable partner. So critical information doesn’t get lost in translation.

02 Multiple Lines of Evidence Made Manageable

Now sponsors can leverage multiple lines of evidence for richer insights and stronger efficacy cases. By connecting multiple perspectives, teams can see more, know more, and do more with the insights they gain. With clearer insights comes momentum you can measure, accelerating progress across the trial lifecycle.

03 The Best of Both Worlds

Signant Health brings deep expertise in eCOA, supporting thousands of trials and hundreds of regulatory submissions. Ametris brings decades of leadership in wearable sensor technology, proven across landmark neuroscience, sleep research, and clinical trials. Together, it’s unmatched.

04 Simplicity at Scale

Complexity slows everything down. Multiple vendors. Fragmented workflows. Operational drag. Now, there’s one partner. One coordinated approach. Simpler execution. Faster progress. Less friction.

05 Investing in What’s Possible

This is more than two companies coming together. It’s a commitment to advancing what clinical evidence can be. Today: A single place to collect complete evidence for your clinical trial. Tomorrow: Unlocking new possibilities. Driving optimal pricing negotiations and differentiating treatments with stronger efficacy cases. Let’s do this.